SCHEMBL23317241

SCHEMBL23317241

CCC(C(=O)Nc1c(C)cccc1C)[PH](c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.49
HSP90AA1 P07900 1/20 0.49
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
THRB P10828 1/20 0.44
POLB P06746 1/20 0.43
CYP3A4 P08684 3/20 0.42
CYP2C19 P33261 3/20 0.42
LMNA P02545 4/20 0.42
MAPT P10636 3/20 0.42
SCN3A Q9NY46 3/20 0.42
CYP1A2 P05177 3/20 0.42
CYP2C9 P11712 3/20 0.42
ALDH1A1 P00352 3/20 0.42
SCN1A P35498 2/20 0.42
SCN2A Q99250 2/20 0.42
MAPK1 P28482 1/20 0.42
MC4R P32245 1/20 0.42
SCN4A P35499 1/20 0.42
MC3R P41968 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23317546 0.89 NPSR1 (0.46) MEN1KMT2APOLBLMNAMAPT
SCHEMBL23317699 0.89 ATM (0.47) ATMHSP90AA1MEN1KMT2ATHRB
SCHEMBL23317225 0.87 HSP90AA1 (0.39) ATMHSP90AA1MEN1KMT2ALMNA
SCHEMBL23317398 0.87 NPSR1 (0.38) ATMHSP90AA1MEN1KMT2ATHRB
SCHEMBL23317183 0.84 KMT2A (0.39) MEN1KMT2ACYP3A4CYP2C19MAPT
SCHEMBL23317230 0.83 CXCR2 (0.35) ATMHSP90AA1MEN1KMT2ATHRB
SCHEMBL23317156 0.82 ATM (0.47) ATMHSP90AA1MEN1KMT2APOLB
SCHEMBL23317414 0.82 ATM (0.54) ATMHSP90AA1MEN1KMT2ATHRB
Bicarbonate SCHEMBL23294944 0.81 ATM (0.47) ATMHSP90AA1MEN1KMT2ATHRB
SCHEMBL23294937 0.81 ATM (0.46) ATMHSP90AA1MEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11701370-B2 Phosphonium ion channel blockers and methods for use Nocion Therapeutics, Inc. (US) 2023-07-18 US disclosed
US-11701370-B2 Phosphonium ion channel blockers and methods for use Nocion Therapeutics, Inc. (US) 2023-07-18 US disclosed
US-20210128589-A1 PHOSPHONIUM ION CHANNEL BLOCKERS AND METHODS FOR USE Nocion Therapeutics, Inc. 2021-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210128589-A1 PHOSPHONIUM ION CHANNEL BLOCKERS AND METHODS FOR USE TRPV1, TRPV5, TRPA1 ATM 4286/4885HSP90AA1 3207/4885MEN1 3153/4885
US-11701370-B2 Phosphonium ion channel blockers and methods for use TRPV1, TRPV5, TRPA1 ATM 4286/4885HSP90AA1 3207/4885MEN1 3153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.